Theravance Biopharma (TBPH) EPS (Basic) (2013 - 2026)
Theravance Biopharma (TBPH) posted quarterly EPS (Basic) of -$0.1 for Q1 2026, up 64.52% year-over-year from -$0.06 in Q1 2025, and down 117.02% quarter-over-quarter from $0.57 in Q4 2025.
Theravance Biopharma (TBPH) EPS (Basic) (2013 - 2026) Analysis & Trends
Theravance Biopharma (TBPH) has reported EPS (Basic) for 14 consecutive years, with -$0.1 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 64.52% year-over-year to -$0.1; the TTM figure through Mar 2026 stood at $1.6 (up 236.47% YoY), while the FY2025 annual figure was $1.39, up 220.6% from the prior year.
- EPS (Basic) declined to -$0.1 in Q1 2026 per TBPH's latest filing, from $0.57 in the prior quarter.
- Across five years, EPS (Basic) topped out at $12.28 in Q3 2022 and bottomed at -$0.34 in Q1 2023.
- Historically, EPS (Basic) has averaged $0.71 across 5 years, with a median of -$0.1 in 2026.
- Annual changes were most pronounced in 2022 — EPS (Basic) jumped 4284.34% — and 2023, when it sank 281.22%.
- Theravance Biopharma's EPS (Basic) stood at $0.05 in 2022, then tumbled by 281.22% to -$0.1 in 2023, then slumped by 231.49% to -$0.32 in 2024, then surged by 279.11% to $0.57 in 2025, then plunged by 117.02% to -$0.1 in 2026.
- Business Quant data shows TBPH's EPS (Basic) at -$0.1 in Q1 2026, $0.57 in Q4 2025, and $0.07 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Theravance Biopharma | 880.59 Mn | 492.93 Mn | - | -0.11 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.11 |
| Mar 31, 2026 | -0.10 |
| Dec 31, 2025 | 0.57 |
| Sep 30, 2025 | 0.07 |
| Jun 30, 2025 | 1.09 |
| Mar 31, 2025 | -0.27 |
| Dec 31, 2024 | -0.32 |
| Sep 30, 2024 | -0.26 |
| Jun 30, 2024 | -0.34 |
| Mar 31, 2024 | -0.24 |
| Dec 31, 2023 | -0.10 |
| Sep 30, 2023 | -0.17 |
| Jun 30, 2023 | -0.28 |
| Mar 31, 2023 | -0.34 |
| Dec 31, 2022 | 0.05 |
| Sep 30, 2022 | 12.28 |
| Jun 30, 2022 | 0.24 |
| Mar 31, 2022 | 0.21 |
| Dec 31, 2021 | 0.37 |
| Sep 30, 2021 | 0.28 |